Stem cell collection in unmanipulated HLA-haploidentical/mismatched related transplantation with combined granulocyte-colony stimulating factor-mobilised blood and bone marrow for patients with haematologic malignancies: the impact of donor characteristics and procedural settings
- PMID: 20136781
- PMCID: PMC2871169
- DOI: 10.1111/j.1365-3148.2010.00990.x
Stem cell collection in unmanipulated HLA-haploidentical/mismatched related transplantation with combined granulocyte-colony stimulating factor-mobilised blood and bone marrow for patients with haematologic malignancies: the impact of donor characteristics and procedural settings
Abstract
Unmanipulated haploidentical/mismatched related transplantation with combined granulocyte-colony stimulating factor-mobilised peripheral blood stem cells (G-PBSCs) and granulocyte-colony stimulating factor-mobilised bone marrow (G-BM) has been developed as an alternative transplantation strategy for patients with haematologic malignancies. However, little information is available about the factors predicting the outcome of peripheral blood stem cell (PBSC) collection and bone marrow (BM) harvest in this transplantation. The effects of donor characteristics and procedure factors on CD34(+) cell yield were investigated. A total of 104 related healthy donors received granulocyte-colony stimulating factor (G-CSF) followed by PBSC collection and BM harvest. Male donors had significantly higher yields compared with female donors. In multiple regression analysis for peripheral blood collection, age and flow rate were negatively correlated with cell yield, whereas body mass index, pre-aphaeresis white blood cell (WBC) and circulating immature cell (CIC) counts were positively correlated with cell yields. For BM harvest, age was negatively correlated with cell yields, whereas pre-BM collection CIC counts were positively correlated with cell yield. All donors achieved the final product of >or=6 x10(6) kg(-1) recipient body weight. This transplantation strategy has been shown to be a feasible approach with acceptable outcomes in stem cell collection for patients who received HLA-haploidentical/mismatched transplantation with combined G-PBSCs and G-BM. In donors with multiple high-risk characteristics for poor aphaeresis CD34(+) cell yield, BM was an alternative source.
Similar articles
-
Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.Biol Blood Marrow Transplant. 2009 Feb;15(2):266-73. doi: 10.1016/j.bbmt.2008.11.029. Biol Blood Marrow Transplant. 2009. PMID: 19167687 Clinical Trial.
-
Cost and outcome in stem cell collections in HLA-haplo identical/mismatched related transplantation with combined granulocyte-colony stimulating factor-mobilized blood and bone marrow for patients with hematologic malignancies.Transfus Apher Sci. 2010 Aug;43(1):23-8. doi: 10.1016/j.transci.2010.05.003. Epub 2010 Jun 15. Transfus Apher Sci. 2010. PMID: 20554478
-
Factors influencing engraftment in HLA-haploidentical/mismatch related transplantation with combined granulocyte-colony stimulating factor-mobilized peripheral blood and bone marrow for patients with leukemia.Transfus Apher Sci. 2011 Jun;44(3):249-55. doi: 10.1016/j.transci.2011.04.005. Epub 2011 May 6. Transfus Apher Sci. 2011. PMID: 21550308
-
[Collection of hematopoietic progenitor cells from healthy donors].Acta Med Croatica. 2009 Jun;63(3):237-44. Acta Med Croatica. 2009. PMID: 19827352 Review. Croatian.
-
Granulocyte-colony stimulating factor primed bone marrow and granulocyte-colony stimulating factor mobilized peripheral blood stem cells are equivalent for engraftment: which to choose?Pediatr Transplant. 2005 Dec;9 Suppl 7:37-47. doi: 10.1111/j.1399-3046.2005.00444.x. Pediatr Transplant. 2005. PMID: 16305616 Review.
Cited by
-
Human umbilical cord blood-derived stromal cells, a new resource in the suppression of acute graft-versus-host disease in haploidentical stem cell transplantation in sublethally irradiated mice.J Biol Chem. 2011 Apr 15;286(15):13723-32. doi: 10.1074/jbc.M110.144691. Epub 2011 Feb 24. J Biol Chem. 2011. PMID: 21349838 Free PMC article.
-
Structural and Functional Characterization of Deceased Donor Stem Cells: A Viable Alternative to Living Donor Stem Cells.Stem Cells Int. 2019 Nov 25;2019:5841587. doi: 10.1155/2019/5841587. eCollection 2019. Stem Cells Int. 2019. PMID: 31885618 Free PMC article.
-
Is Haploidentical Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide Feasible in Sub-Saharan Africa?Transplant Cell Ther. 2021 Dec;27(12):1002.e1-1002.e8. doi: 10.1016/j.jtct.2021.08.018. Epub 2021 Aug 31. Transplant Cell Ther. 2021. PMID: 34478910 Free PMC article.
-
The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation.Bone Marrow Transplant. 2020 Jan;55(1):12-24. doi: 10.1038/s41409-019-0499-z. Epub 2019 Mar 4. Bone Marrow Transplant. 2020. PMID: 30833742 Review.
-
Index of CD34+ Cells and Mononuclear Cells in the Bone Marrow of Spinal Cord Injury Patients of Different Age Groups: A Comparative Analysis.Bone Marrow Res. 2012;2012:787414. doi: 10.1155/2012/787414. Epub 2012 Jul 5. Bone Marrow Res. 2012. PMID: 22830032 Free PMC article.
References
-
- Anderlini P, Donato M, Chan KW, Huh YO, Gee AP, Lauppe MJ, Champlin RE, Korbling M. Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience. Transfusion. 1999;39:555–560. - PubMed
-
- Anderlini P, Przepiorka D, Seong C, Smith TL, Huh YO, Lauppe J, Champlin R, Korbling M. Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim. Transfusion. 1997;37:507–512. - PubMed
-
- Aversa F, Reisner Y, Martelli MF. The haploidentical option for high-risk haematological malignancies. Blood Cells, Molecules, and Diseases. 2008;40:8–12. - PubMed
-
- Ball LM, Bernardo ME, Roelofs H, Lankester A, Cometa A, Egeler RM, Locatelli F, Fibbe WE. Cotransplantation of ex vivo-expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood. 2007;110:2764–2767. - PubMed
-
- Cassens U, Barth I, Baumann C, Fischer RJ, Kienast J, Vormoor J, Sibrowski W. Factors affecting the efficacy of peripheral blood progenitor cells collections by large-volume leukapheresis with standardized processing volumes. Transfusion. 2004;44:1593–1602. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous